These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2710641)

  • 1. A comparison of carbamazepine divitabs with carbamazepine normal formulation in psychiatric and oligophrenic patients. Preliminary pharmacokinetic results.
    Loonen AJ; Toll PJ; Nijdam JR
    Pharm Weekbl Sci; 1989 Feb; 11(1):23-6. PubMed ID: 2710641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of carbamazepine Divitabs and a normal carbamazepine preparation in psychiatric and oligophrenic patients.
    Nijdam JR; Doorschot CH; van Bavel LP; Loonen AJ
    Pharmacopsychiatry; 1992 May; 25(3):145-9. PubMed ID: 1635933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of conventional and controlled-release carbamazepine in healthy subjects.
    Larkin JG; McLellan A; Munday A; Sutherland M; Butler E; Brodie MJ
    Br J Clin Pharmacol; 1989 Mar; 27(3):313-22. PubMed ID: 2655682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration.
    Wangemann M; Retzow A; Evers G; Mazur D; Schug B; Blume H
    Arzneimittelforschung; 1998 Dec; 48(12):1131-7. PubMed ID: 9893926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral effects of carbamazepine capsules and Divitabs in psychiatric patients.
    Loonen AJ; Doorschot CH; Van Bavel LP; Groot B; De Blok HJ; Krijgsman LJ; Van Dongen PH; Jaspers AA; Vanbrabant LC
    Pharm Weekbl Sci; 1991 Feb; 13(1):39-40. PubMed ID: 2034516
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.
    Garnett WR; Levy B; McLean AM; Zhang Y; Couch RA; Rudnic EM; Pellock JM; Belendiuk GW
    Epilepsia; 1998 Mar; 39(3):274-9. PubMed ID: 9578044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability study of a conventional and two controlled release oral formulations of Tegretol (carbamazepine)--200 mg.
    Revankar SN; Bhatt AD; Desai ND; Bolar HV; Sane SP; Tipnis HP
    J Assoc Physicians India; 1999 Sep; 47(9):886-9. PubMed ID: 10778658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.
    Patsalos PN
    Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.
    Eeg-Olofsson O; Nilsson HL; Tonnby B; Arvidsson J; Grahn PA; Gylje H; Larsson C; Norén L
    J Child Neurol; 1990 Apr; 5(2):159-65. PubMed ID: 2111837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation.
    Kaski M; Heinonen E; Sivenius J; Tuominen J; Anttila M
    J Ment Defic Res; 1991 Jun; 35 ( Pt 3)():231-9. PubMed ID: 1920391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic comparison of tablet and suspension dosage forms of carbamazepine.
    Wada JA; Troupin AS; Friel P; Remick R; Leal K; Pearmain J
    Epilepsia; 1978 Jun; 19(3):251-5. PubMed ID: 679894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily fluctuation of plasma levels with conventional and controlled-release carbamazepine: correlation with adverse effects.
    Bareggi SR; Tata MR; Guizzaro A; Pirola R; Parisi A; Monza CG
    Int Clin Psychopharmacol; 1994; 9(1):9-16. PubMed ID: 8195585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-dose pharmacokinetic study with a slow-release carbamazepine preparation.
    Reunanen M; Heinonen E; Anttila M; Järvensivu P; Lehto H; Hokkanen E
    Epilepsy Res; 1990 Jul; 6(2):126-33. PubMed ID: 2387286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.
    McKee PJ; Blacklaw J; Carswell A; Gillham RA; Brodie MJ
    Br J Clin Pharmacol; 1993 Sep; 36(3):257-61. PubMed ID: 9114913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single and multiple dose bioavailability study with carbamazepine 400 mg retard tablets with reference to enzyme autoinduction and circadian time differences.
    Hoffmann C; Zschiesche M; Franke G; Hoffmann A; Terhaag B; Möritz KU; Siegmund W
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):496-503. PubMed ID: 9401830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets.
    Ikinci G; Capan Y; Senel S; Dalkara T; Hincal AA
    Pharmazie; 1999 Feb; 54(2):139-41. PubMed ID: 10084159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures.
    Van Der Meyden CH; Kruger AJ; Müller FO; Rabie W; Schall R
    Epilepsia; 1994; 35(1):189-94. PubMed ID: 8112244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy.
    Arvidsson J; Nilsson HL; Sandstedt P; Steinwall G; Tonnby B; Flesch G
    J Child Neurol; 1995 Mar; 10(2):114-7. PubMed ID: 7782600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A practical study of the efficacy of a delayed-action preparation of carbamazepine (Tegretol CR 400) in the treatment of patients with partial epilepsy ].
    Vojvodić NM; Sokić DV; Janković SM; Lević Z
    Srp Arh Celok Lek; 2002; 130(1-2):19-26. PubMed ID: 12073283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations into the relative bioavailability of carbamazepine after single oral administration of three test batches of a carbamazepine-containing sustained release formulation in healthy subjects.
    Schulz HU; Düsing R; Grunwald F; Czaja J; Lührmann B; Frecks HJ
    Int J Clin Pharmacol Ther Toxicol; 1992 Apr; 30(4):139-44. PubMed ID: 1572759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.